Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117320) titled 'Shanghai Clinical Cohort - Pancreatic Cancer' on Jan. 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: ShangHai Changhai Hospital
Condition:
Pancreas cancer
Intervention:
High-risk cohort:NA
Cancer precursor lesion cohort:NA
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-04-01
Target Sample Size: High-risk cohort:480;Cancer precursor lesion cohort:1160;Early, middle and late-stage pancreatic cancer cohort:2360;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=288270
Disclaimer: Curated by ...